CO6280480A2 - Ciclopentanos sustituidos que tienen actividad prostaglandina - Google Patents

Ciclopentanos sustituidos que tienen actividad prostaglandina

Info

Publication number
CO6280480A2
CO6280480A2 CO10066597A CO10066597A CO6280480A2 CO 6280480 A2 CO6280480 A2 CO 6280480A2 CO 10066597 A CO10066597 A CO 10066597A CO 10066597 A CO10066597 A CO 10066597A CO 6280480 A2 CO6280480 A2 CO 6280480A2
Authority
CO
Colombia
Prior art keywords
fractions
compound
formula
cyclopentans
prostaglandina
Prior art date
Application number
CO10066597A
Other languages
English (en)
Spanish (es)
Inventor
Yariv Donde
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40524829&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO6280480(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of CO6280480A2 publication Critical patent/CO6280480A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D333/40—Thiophene-2-carboxylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
CO10066597A 2007-11-09 2010-06-02 Ciclopentanos sustituidos que tienen actividad prostaglandina CO6280480A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US98684907P 2007-11-09 2007-11-09
US12/265,062 US9006464B2 (en) 2007-11-09 2008-11-05 Substituted cyclopentanes having prostaglandin activity

Publications (1)

Publication Number Publication Date
CO6280480A2 true CO6280480A2 (es) 2011-05-20

Family

ID=40524829

Family Applications (1)

Application Number Title Priority Date Filing Date
CO10066597A CO6280480A2 (es) 2007-11-09 2010-06-02 Ciclopentanos sustituidos que tienen actividad prostaglandina

Country Status (21)

Country Link
US (1) US9006464B2 (enExample)
EP (1) EP2217581B1 (enExample)
JP (1) JP2011503089A (enExample)
KR (1) KR20100101097A (enExample)
CN (2) CN101952261B (enExample)
AR (1) AR069228A1 (enExample)
AU (1) AU2008324793B2 (enExample)
BR (1) BRPI0818902A2 (enExample)
CA (1) CA2705150C (enExample)
CL (1) CL2008003332A1 (enExample)
CO (1) CO6280480A2 (enExample)
DK (1) DK2217581T3 (enExample)
ES (1) ES2432058T3 (enExample)
IL (1) IL205604A (enExample)
MX (1) MX2010005105A (enExample)
NZ (1) NZ585517A (enExample)
RU (1) RU2481339C2 (enExample)
TW (1) TWI411438B (enExample)
UA (1) UA99840C2 (enExample)
WO (1) WO2009061811A1 (enExample)
ZA (1) ZA201003304B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8722097B2 (en) 2004-04-30 2014-05-13 Allergan, Inc. Oil-in-water method for making polymeric implants containing a hypotensive lipid
US7799336B2 (en) 2004-04-30 2010-09-21 Allergan, Inc. Hypotensive lipid-containing biodegradable intraocular implants and related methods
US7993634B2 (en) 2004-04-30 2011-08-09 Allergan, Inc. Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods
US8673341B2 (en) * 2004-04-30 2014-03-18 Allergan, Inc. Intraocular pressure reduction with intracameral bimatoprost implants
US9498457B2 (en) 2004-04-30 2016-11-22 Allergan, Inc. Hypotensive prostamide-containing biodegradable intraocular implants and related implants
US20100247606A1 (en) * 2009-03-25 2010-09-30 Allergan, Inc. Intraocular sustained release drug delivery systems and methods for treating ocular conditions
EP3991734B1 (en) 2019-06-28 2024-11-27 Gurus BioPharm Inc. Agent for the treatment of alopecia and promoting hair growth

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7012A (en) * 1850-01-15 Improvement in mowing-machines
IE37602B1 (en) * 1971-05-11 1977-08-31 Ici Ltd Cyclopentane derivatives
JPS5623984B2 (enExample) * 1973-04-19 1981-06-03
US4065472A (en) * 1975-09-29 1977-12-27 Pfizer Inc. 5-(2-Carboxythiophen-5-yl)-16-aryloxy-α-tetranor-ω-tetranorprostaglandins
GB1563201A (en) * 1975-11-05 1980-03-19 Shell Int Research Preparation of herbicidally acitve alanine derivatives
US5698598A (en) * 1995-08-04 1997-12-16 Allergan EP2 -receptor agonists as agents for lowering intraocular pressure
US5877211A (en) * 1997-11-21 1999-03-02 Allergan EP2 receptor agonists as neuroprotective agents for the eye
AU2211700A (en) * 1998-12-24 2000-07-31 Alcon Laboratories, Inc. Prostaglandin e agonists for treatment of glaucoma
US7091231B2 (en) 2004-12-10 2006-08-15 Allergan, Inc. 12-Aryl prostaglandin analogs
US7585895B2 (en) * 2005-12-06 2009-09-08 Allergan, Inc. Therapeutic substituted cyclopentanes
US7427685B2 (en) * 2005-12-06 2008-09-23 Allergan, Inc. Therapeutic substituted cyclopentanes
US7439372B2 (en) * 2006-05-03 2008-10-21 Allergan, Inc. Therapeutic compounds
ATE496903T1 (de) * 2007-02-01 2011-02-15 Allergan Inc Thiophenderivate als medikamente zur behandlung von okularer hypertonie

Also Published As

Publication number Publication date
US20090124676A1 (en) 2009-05-14
WO2009061811A8 (en) 2009-07-02
EP2217581B1 (en) 2013-07-31
CL2008003332A1 (es) 2011-08-12
RU2010122681A (ru) 2011-12-20
CN102977048A (zh) 2013-03-20
AR069228A1 (es) 2010-01-06
BRPI0818902A2 (pt) 2015-05-12
CA2705150C (en) 2016-06-14
MX2010005105A (es) 2010-05-27
DK2217581T3 (da) 2013-10-21
UA99840C2 (ru) 2012-10-10
ES2432058T3 (es) 2013-11-29
RU2481339C2 (ru) 2013-05-10
CA2705150A1 (en) 2009-05-14
WO2009061811A1 (en) 2009-05-14
TWI411438B (zh) 2013-10-11
KR20100101097A (ko) 2010-09-16
US9006464B2 (en) 2015-04-14
NZ585517A (en) 2012-08-31
TW200934500A (en) 2009-08-16
AU2008324793B2 (en) 2013-12-05
EP2217581A1 (en) 2010-08-18
ZA201003304B (en) 2014-03-26
JP2011503089A (ja) 2011-01-27
CN101952261B (zh) 2013-06-12
AU2008324793A1 (en) 2009-05-14
CN101952261A (zh) 2011-01-19
IL205604A (en) 2014-06-30
IL205604A0 (en) 2010-11-30

Similar Documents

Publication Publication Date Title
CY1115262T1 (el) Ανταγωνιστες trpv1 και χρησεις αυτων
PE20141583A1 (es) Nuevos derivados de piridina
CR11470A (es) Compuestos organicos
CY1119547T1 (el) Ενωσεις, συνθεσεις και μεθοδοι χρησιμες για κινητοποιηση χοληστερολης
UY31084A1 (es) Compuestos de azaindol para la inhibicion de b-secretasa
EA201100037A1 (ru) Органические соединения
CR9587A (es) Derivados de piridazina
MX2013003365A (es) Composicion farmaceutica.
NI201400043A (es) 4 - fenil - piridinas sustituidas para el tratamiento de enfermedades relacionadas con el receptor de nk1
EP3842412A4 (en) BIODEGRADABLE COMPOUND, LIPID PARTICLES, COMPOSITION WITH LIPID PARTICLES AND KIT
EA201301240A1 (ru) Полиморфная форма бензоата линаглиптина
EA201390843A1 (ru) Применение агониста toll-подобного рецептора для лечения рака
ECSP10010439A (es) Antagonistas n,n-disustituidos de aminoalquilbifenilo de receptores d2 de prostaglandina
EA201401193A1 (ru) Триарильные соединения и композиции, их содержащие
EP2789245A4 (en) EMULSION COMPOSITION AND COMPOSITION / INGREDIENTS
MA38404B1 (fr) Nouveaux dérivés de pyridine
MX343611B (es) Composicion de control de fitoenfermedades y su uso.
CO6852097A2 (es) Agentes de coalescencia amigables con el medio ambiente
CO6710915A2 (es) Composiciones farmacéuticas que contienen un inhibidor de dgat1 ácido 4-(4-(5-6(- trifluorometil-piridin -3- ilamino)-piridin- 2-il)fenil)cicloheiyl)-acético o sales del mismo
BR112015015368A2 (pt) composições de absorventes de dejetos de animais revestidas debaixa densidade
BRPI0819566A2 (pt) "composições antissépticas para tecidos"
EP2214625A4 (en) EMULSION COMPOSITION
BR112014004464A2 (pt) composições de limpeza e agente de captura de sujeira para limpar objetos
UY30787A1 (es) "inhibidores benzoimidazolicos de trpv1"
CL2008001990A1 (es) Compuestos derivados de amino-quinazolinas sustituidas; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de alzheimer.

Legal Events

Date Code Title Description
FG Application granted